Last Wednesday, Dec 17, 2025, marked a milestone with the first da Vinci 5 robotic surgical system in Spain arriving at Rey Juan Carlos University Hospital — and yes, we are excited about what it represents. But beyond the buzz and the impeccable engineering, we want a grounded, surgical perspective on what da Vinci 5 really brings to the table.
What’s New in da Vinci 5?
Intuitive Surgical’s fifth-generation multi-port robot builds on the well-established Xi platform rather than reinventing it. The headline innovations are largely software and data-centric, enabled by a massive boost in onboard computing power (over 10 000× that of the Xi). These include:
- Force Feedback (Haptics): Surgeons can now feel forces at the instrument tips, providing tactile cues about tissue interaction — something never present in prior da Vinci models. Early data suggest this can reduce applied force (and thus potential tissue trauma), although its clinical impact remains to be defined beyond preclinical metrics.
- Advanced Data & AI-Enabled Insights: Leveraging cloud connectivity and onboard analytics, da V5 can gather and process surgical data globally. This enables video replay, digital case analysis, performance metrics, and personalized coaching, hints of what AI-driven surgical intelligence might become.
- Smart OR Integration & Workflow Enhancements: Features like in-console video review, remote software updates (Network CCM), and streamlined controls aim to improve efficiency and ergonomics.
“The new surgeon console represents a genuine
advance” (1).
In short: more data, more feedback, more computing — but not a fundamentally new surgical action. It’s a tool refinement, not a tool revolution.
So… What’s the Actual Surgical Leap?
From a pure surgical-technique standpoint, da Vinci 5 does not offer instruments or mechanics that enable new procedures or new anatomical approaches compared to the Xi. It’s the same multi-port framework, with improved sensing and a richer data layer — but the core mechanical capabilities are still the same robotic arms and tools surgeons have used for years.
That’s the heart of our viewpoint: Yes, it’s absolutely cool — and a real step forward in surgical user experience and data intelligence — but it doesn’t change what we can do in Head&Neck Robotic Surgery compared to the Xi (neither in any other surgical speciality).
Why We Still Prefer da Vinci SP for Head & Neck
For transoral and other constrained spaces characteristic of head & neck surgery, the single-port (SP) system remains technically superior.
The SP design is inherently suited to narrow corridors like the oropharynx, larynx, and deep spaces — offering better access, fewer arm collisions, and more direct angulation than a multi-port robot. The multi-port da Vinci 5 simply doesn’t address the spatial challenges specific to many head & neck procedures.
Moreover, “... force feedback, which is currently available only on a limited set of instruments (e.g., fenestrated bipolar, needle driver). In practice, we observed limited utility for TORS… This finding mirrors prior observations SP series, where improved instrument flexibility and triangulation were valued more than haptic cues for functional transoral resections” (1).
So while da Vinci 5 brings wonderful “digital age” features, it doesn’t materially improve the robot’s reach where we need it most.
Regulatory Status in Head & Neck Surgery
It’s important to note that da Vinci 5 is not formally accredited for head & neck robotic surgery (e.g., TORS) in its official indications — at least according to current FDA and CE Mark listings, which focus on urology, gynecology, general laparoscopic and thoracoscopic procedures.
That said, clinical experience in TORS with the multi-port da Vinci 5 is already appearing in the literature (see references bellow). There is no additional accreditation required (as for the SP system), so surgeons are just transitioning from dV Xi to dV 5.
“The learning curve for experienced Xi users appeared negligible” (1)
Importantly, there is no inherent medical reason — technical or safety-based — why da Vinci 5 could not be used for TORS and other Head&Neck robotic procedures by surgeons already experienced with multi-port systems. It’s a matter of regulatory labelling vs. actual surgical practice, not a statement that it’s unsafe or inappropriate. Unlike da Vinci SP, which does have formal specific indications for transoral use, da Vinci 5’s labelling just hasn’t been tailored to include TORS yet.
Looking Ahead: AI, Coaching, and Surgical Data Science
Where da Vinci 5 may make its most lasting impact is less in mechanical action and more in cognitive support. The ability to:
- objectively analyze thousands of surgical cases,
- provide skill benchmarking,
- deliver personalized coaching, and
- integrate AI-driven insights in real time
… poses a gateway toward truly smart robotic surgery. That’s where the future lies — but that future isn’t here in the sense of fundamentally new surgical ability; it’s here as an enhanced learning and quality platform.
We will tell you soon about our clinical experience with the da Vinci 5.
J Granell. Dec 19, 2025
References
(1) Tsur N, Costantino A, Magnuson JS. Initial clinical experience with the da Vinci 5 in transoral robotic surgery. J Robot Surg. 2025 Nov 11;20(1):1. doi: 10.1007/s11701-025-02911-3.
(2) Naruekon J, Duvvuri U, Prince AC, Pujol G, Vaezi A, Nance M, Jacobson A. Da Vinci 5 in transoral robotic surgery: first impression. J Robot Surg. 2025 Nov 5;19(1):755. doi: 10.1007/s11701-025-02949-3.
Related Posts (da Vinci 5)
da Vinci 5 July 6, 2025
CE Mark for da Vinci 5 July 2, 2025
da Vinci 5 April 10, 2024
